HIV News and Research

RSS

Slow-release HIV vaccine shows promise in preclinical trials

A new slow-release vaccine has been shown to boost the immune system’s response to the HIV virus. The vaccine is given in small doses over a period of days, compared to one large dose.

10 May 2019

New clinical trial to compare effectiveness of injectable drugs and oral medications to treat HIV

Researchers at the University of Colorado Anschutz Medical Campus, working with the National Institutes of Health, will conduct a clinical trial beginning this month to determine if monthly injections of anti-viral drugs are more effective at suppressing the HIV virus than daily pills in a population for whom daily adherence has been a challenge.

10 May 2019

Study evaluates long-acting HIV therapy in patients unable to adhere to strict daily regimens

A clinical trial to evaluate long-acting antiretroviral therapy for maintaining HIV suppression in people for whom adhering to conventional daily oral ART has been a challenge has begun at research sites across the United States.

9 May 2019

Better training needed for internal medicine residents to combat HIV epidemic, survey suggests

The nation's HIV epidemic remains stubbornly persistent, with almost 40,000 new infections annually in the United States.

8 May 2019

Researchers create ‘mini-guts’ to explore how gut epithelium respond to gluten in celiac patients

In pursuit of a novel tool for the research and treatment of celiac disease, scientists at the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital have validated the use of intestinal organoids.

8 May 2019

“Without Antibiotics, I Cannot Treat”: Examining Antibiotic Resistance Drivers in India

Mohit Nair discusses the issue of antibiotic resistance in India and the work that MSF is doing to improve awareness and reduce the misuse of antibiotics.

7 May 2019

Immediate HIV treatment initiation has improved but not yet universal in NYC, study finds

A new study published in the Journal of Infectious Diseases found that immediate treatment initiation for HIV infection has improved since local and federal guidelines began to recommend universal treatment for all persons diagnosed with HIV, regardless of their disease stage.

7 May 2019

Research in preclinical models suggests promising anti-HIV-1 vaginal microbicide

A vaginal microbicide that could prevent sexual transmission of HIV-1 in women has tremendous potential for saving lives and helping staunch an epidemic.

7 May 2019

Stop the stigma: 'HIV transmission with suppressive ART is zero'

A new study has provided further evidence that taking antiretroviral therapy (ART) reduces the risk of HIV being transmitted between gay couples to effectively zero.

3 May 2019

Discovery of small-molecule inhibitors could enable precise control over CRISPR-Cas9 genome editing

The discovery of the first small-molecule inhibitors of the Streptococcus pyogenes Cas9 (SpCas9) protein could enable more precise control over CRISPR-Cas9-based genome editing, researchers report May 2 in the journal Cell.

3 May 2019

Researchers win $6.2 million grant to study HIV/TB co-infection in children

About a third of us are walking around with the bacteria that causes tuberculosis in our bodies, but most don't actually end up with TB. For children living with HIV - about 2 million at last estimate - it's a different story.

1 May 2019

Children under 3 years old are most vulnerable to the effects of adversity, study finds

A Massachusetts General Hospital study has found evidence that children under 3 years old are most the vulnerable to the effects of adversity - experiences including poverty, family and financial instability, and abuse - on their epigenetic profiles, chemical tags that alter gene expression and may have consequences for future mental health.

1 May 2019

Will gene-editing of human embryos ever be justifiable?

World-leading medical ethicist Professor Arthur Caplan has published a series of recommendations with the aim of addressing worldwide concerns over gene editing of human embryos.

30 Apr 2019

Angiotensin receptor blockers could improve response to cancer immunotherapy

A research team led by investigators at Massachusetts General Hospital and the Massachusetts Institute of Technology has found that combining a specialized version of an antihypertension drug with immune checkpoint blockers could increase the effectiveness of cancer immunotherapies.

30 Apr 2019

Study: Child and adolescent health improved but maternal mortality worsened in the U.S.

The United States is one of only eight countries in the world where decreases in child and adolescent mortality over a 27-year period haven't also been matched by reductions in maternal mortality, according to a new scientific study.

30 Apr 2019

Study documents experience of African-American moms raising their children in the US

African-American moms share many traits with helicopter parents, specifically when it comes to being overprotective and hypervigilant about their children's lives. But their goal is not only to get them into college. It's survival.

30 Apr 2019

United Nations sounds alarm bell on drug-resistant infections

According to a new report from a United Nations Committee, antibiotic resistance levels are at an all time high and are the reason behind common infections becoming difficult to treat.

30 Apr 2019

Study describes new viral molecular evasion mechanism used by cytomegalovirus

A study published in the journal PLOS Pathogens describes a new viral molecular evasion mechanism used by cytomegalovirus to interfere in the immune response of the infected host.

30 Apr 2019

Women pay more for over-the-counter facial moisturizing products, MGH study finds

Over-the-counter facial moisturizers are a widely-used and commonly recommended skin care product, but a new study from dermatologists at Massachusetts General Hospital finds that, when it comes to price, men's and women's products are not considered equal.

29 Apr 2019

Kamari partners with Kinect to support new HIV testing programs in Africa

Kamari, a project building an ecosystem of mobile gaming and lotteries with existing licenses in over seven African countries, has partnered with Kinect, a blockchain-based health technology platform focused on advancing the United Nations Sustainable Development Goals, to fund and promote new HIV testing programmes in countries across the African continent.

29 Apr 2019

HIV News and Research

Slow-release HIV vaccine shows promise in preclinical trials

New clinical trial to compare effectiveness of injectable drugs and oral medications to treat HIV

Study evaluates long-acting HIV therapy in patients unable to adhere to strict daily regimens

Better training needed for internal medicine residents to combat HIV epidemic, survey suggests

Researchers create ‘mini-guts’ to explore how gut epithelium respond to gluten in celiac patients

“Without Antibiotics, I Cannot Treat”: Examining Antibiotic Resistance Drivers in India

Immediate HIV treatment initiation has improved but not yet universal in NYC, study finds

Research in preclinical models suggests promising anti-HIV-1 vaginal microbicide

Stop the stigma: 'HIV transmission with suppressive ART is zero'

Discovery of small-molecule inhibitors could enable precise control over CRISPR-Cas9 genome editing

Researchers win $6.2 million grant to study HIV/TB co-infection in children

Children under 3 years old are most vulnerable to the effects of adversity, study finds

Will gene-editing of human embryos ever be justifiable?

Angiotensin receptor blockers could improve response to cancer immunotherapy

Study: Child and adolescent health improved but maternal mortality worsened in the U.S.

Study documents experience of African-American moms raising their children in the US

United Nations sounds alarm bell on drug-resistant infections

Study describes new viral molecular evasion mechanism used by cytomegalovirus

Women pay more for over-the-counter facial moisturizing products, MGH study finds

Kamari partners with Kinect to support new HIV testing programs in Africa

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News